Aerotek Scientific Acquires Scientific Division of KForce
Aerotek’s clients gain increased access to qualified candidates for their positions with the company's acquisition of Kforce’ scientific division.
Aerotek Scientific® LLC, a subsidiary of Aerotek, Inc., is excited to announce the acquisition of the scientific division of Kforce. Aerotek (www.aerotek.com) is a leading provider of technical, professional and industrial recruiting and staffing. Financial details of the acquisition have not been disclosed by company officials.
Aerotek acquired the employees, clients, contractors, and relevant data of the scientific division of Kforce. Staff previously employed by the scientific division of Kforce will continue to service their clients and contractors while working for Aerotek Scientific.
Aerotek Scientific places candidates of all levels at a variety of companies in many industries including: pharmaceuticals, biotechnology, healthcare, food & beverage, clinical research, chemical and plastics. The scientific division of Kforce’s similar focus on these markets complements Aerotek’s existing structure and will expand the company throughout the scientific industry. Kforce will retain the recruitment services that apply to the clinical trials industry.
“The acquisition of the scientific division of Kforce strengthens the presence of Aerotek Scientific within niche scientific industries nationwide,” said Thomas M. Thornton, president and chief executive officer of Aerotek. In addition to the internal growth from which our company will benefit, former Kforce Scientific and existing Aerotek clients now have access to a larger pool of qualified candidates for their positions, and contract employees have significantly more jobs available to them through our services.”
As technologies evolve and new career specialties emerge, the market for scientific professionals has continued to increase. The demand for qualified, experienced talent in scientific industries has become progressively competitive. The acquisition of the scientific division of Kforce bolsters Aerotek’s collective expertise and reinforces the company’s position as a leader in this marketplace.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
